The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1100 ET – Bayer is expecting a historically high U.S. corn ...

BAYRY beats on Q2 earnings and raises 2025 sales outlook (on a currency-adjusted basis) as pharma growth offsets currency and ...

Bayer on Wednesday said it would be forced to stop its U.S. production of widely-used farming weedkiller glyphosate unless ...

The German giant has already trimmed more than 10,000 employees since initiating a massive restructuring initiative in July ...

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

Investor concerns that Bayer's earnings were inflated by soccer player transfer fees rather than supported by its core ...

As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...